As part of BHIVA’s ongoing commitment to continued professional development we have recorded the first 3 in a series of webcasts on the following topics;
Antiretroviral treatment for adults living with HIV-1 2022
Dr Laura Waters
TasP
Professor Sarah Fidler
Pregnancy Guidelines
Dr Yvonne Gilleece
The latest webcast (Antiretroviral treatment for adults living with HIV-1 2022) is open access and available for all to view below.
The other two webcasts (TasP and Pregnancy Guidelines) are available to all BHIVA members.
This project has been made possible through the support of an Independent Medical Grant from Gilead Sciences and we will continue to build upon the topics over the coming months.
The PrEP Impact Trial was set up in 2017 to recruit 26,000 participants who were at a high risk of HIV infection in England over 3 years. Early reports signalled a concerning disparity in PrEP uptake. The numbers of women, trans and non-binary people, racially minoritised populations and heterosexual men recruited into the trial were significantly lower than men who have sex with men, at approximately 5% of the overall recruitment.
The Women and Other Groups subgroup of the PrEP Impact Trial’s community advisory board was formed in response to this inequity to advance the PrEP agenda of self-identifying women, including trans women and non-binary people, trans men, racially minoritised populations, heterosexual men and those selling sex or working in the sex industry.
A key activity of this subgroup, in conjunction with collaborating organisations and funded by an NHSE grant, has been to commission and co-produce a suite of community-led and community co-designed PrEP awareness videos advocating for PreP for all.
The first of two symposia exploring race, ethnicity and healthcare outcomes delivered by SWIFT (Supporting Women with HIV Information Network) and sponsored by the British HIV Association.
Part 1 - Friday 24th July 2020
Part 2 - Friday 11th September 2020